Bill Texts: NJ A2830 | 2020-2021 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced - Dead) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2830 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2020-02-20HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A2830

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey A2830 currently on file.

Social Comments on NJ A2830

feedback